As of June 17, 2025, Xtant Medical Holdings Inc (XTNT) reports a Gross Margin of 58.17%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Xtant Medical Holdings Inc's Gross Margin
Over recent years, Xtant Medical Holdings Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 58.17% |
| 2023-12-31 | 60.75% |
| 2022-12-31 | 55.44% |
| 2021-12-31 | 58.79% |
| 2020-12-31 | 64.48% |
This slight downward trend highlights how Xtant Medical Holdings Inc manages its operational efficiency and pricing power over time.
Comparing Xtant Medical Holdings Inc's Gross Margin to Peers
To better understand Xtant Medical Holdings Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Xtant Medical Holdings Inc (XTNT) | 58.17% |
| Sanara Medtech Inc (SMTI) | 90.61% |
| Vycor Medical Inc (VYCO) | 89.50% |
| SI-BONE Inc (SIBN) | 79.03% |
| Procyon Corp (PCYN) | 78.07% |
| OrthoPediatrics Corp (KIDS) | 72.58% |
Compared to its competitors, Xtant Medical Holdings Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.